Streetbeat News

Partnerships

BEN

Franklin Templeton has expanded its partnership with Janney to deliver the Canvas Custom Indexing Platform. This move makes the platform available to Janney's financial advisors.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:29 pm

WISH

ContextLogic Inc (NASDAQ:WISH) shares are trading lower after a rally on Monday. The company announced a new partnership with parcel pick-up and drop-off network company PUDO. The partnership will allow Wish customers to pick up packages from PUDO's network across the U.S. and Canada. By the end of the year, the company expects to have 24,000 pick-up points available to customers globally.

Portfolio Pulse from Adam Eckert

September 26, 2023 | 1:25 pm

AFRM

WEAV

Weave (NYSE:WEAV) has announced a partnership with Affirm (NASDAQ:AFRM) to integrate Affirm's pay-over-time options with Weave's patient experience platform. This collaboration will provide flexible payment options for eligible patients, making healthcare more accessible and affordable. The partnership will also allow healthcare practices to receive payments quicker than before.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:24 pm

GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) has signed a commercial license agreement with ProBioGen for its AGE1.CR.pIX® suspension cell line. This will enhance GeoVax's manufacturing capabilities for its entire Modified Vaccinia Ankara (MVA) based vaccine portfolio. The AGE1.CR.pIX cell line enables high-yield and scalable production, leading to cost-effectiveness and increased productivity for vaccine developers. Financial terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:23 pm

SNX

Spin.AI and TD SYNNEX have partnered to provide SaaS security solutions to resellers and customers. The all-in-one SaaS security platform, SpinOne, will be available to TD SYNNEX partners and customers worldwide, aiming to reduce security and compliance risks associated with data theft, leak, and loss.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:23 pm

TBLA

Taboola (NASDAQ:TBLA) has announced a multi-year deal with Advance Local to increase user engagement and monetization opportunities. Advance Local will use Taboola's suite of products to grow its audience, optimize user engagement, and drive revenue. The deal includes the use of Taboola Feed, mid-article and right rail placements, and testing of additional offerings such as Header Bidding and Taboola Turnkey Commerce.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:22 pm

AMZN

DRCT

Direct Digital Holdings, Inc. (NASDAQ:DRCT) has announced a collaboration with Amazon Publisher Services. The collaboration will see Direct Digital's Supply-Side Platform, Colossus SSP, integrate with Amazon's Transparent Ad Marketplace (TAM). This integration will provide Colossus SSP's publishers with access to TAM's server-side header bidding solutions, offering a direct auction approach. The collaboration is expected to provide direct, premium, transparent, and scalable advertising opportunities.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:15 pm

JPM

Jamie Dimon, CEO of JPMorgan Chase & Co, has expressed his support for the strengthening of economic ties between the U.S. and India. He praised India's economic potential and its recent inclusion in JP Morgan’s bond index, which he anticipates will attract billions in overseas investment. The strengthening U.S.-India relationship is seen as a counterbalance to China's growing regional dominance.

Portfolio Pulse from Arpit Nayak

September 26, 2023 | 1:13 pm

CTLT

Melt Pharmaceuticals has entered into an exclusive development and license agreement with Catalent for its Zydis fast-dissolve technology. The technology will be used in MELT-300, a needle- and opioid-free formulation for procedural sedation during cataract surgery. MELT-300, which combines fixed doses of midazolam and ketamine, is administered sublingually and uses Zydis ODT technology to rapidly dissolve the tablet for absorption. Melt Pharmaceuticals is currently in discussions with the FDA on the Phase 3 program, which is expected to begin in early 2024.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:13 pm

NUZE

NuZee, Inc. (NASDAQ:NUZE) has announced an expanded relationship with one of its largest customers, which could result in over $2 million in incremental annual revenue. The company will begin supplying additional products, including bagged coffee, to the customer starting in fiscal year 2024. This move is seen as a major step towards growing and diversifying NuZee's business.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:09 pm